Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for Prevention of Contrast-Induced Nephropathy in ACS
NCT06429345Phase 4Recruiting
- Sponsor
- Ain Shams University
- Start
- Jun 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Coenzyme Q10 mucoadhesive tablets in contrast-induced nephropathy (CIN), sponsored by Ain Shams University. Started Jun 2024; status: recruiting.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT06429345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06429345.